Clincosm LogoSign in Get a demo

acute myeloid leukemia

Showing NaN - NaN of 58
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-500)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Los Angeles, California
  • +9 more
Jun 27, 2023

Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +190 more
Jan 30, 2023

Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Biospecimen Collection
  • +5 more
  • Buffalo, New York
  • +1 more
Jan 27, 2023

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Orca-T
  • Standard-of-Care
  • Duarte, California
  • +13 more
Jan 25, 2023

Solid Tumor, Colorectal Cancer, Gastric Cancer Trial in United States (IGM-8444, FOLFIRI, Bevacizumab (and approved

Recruiting
  • Solid Tumor
  • +7 more
  • Duarte, California
  • +11 more
Jan 6, 2023

Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax, Midostaurin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +9 more
Jan 3, 2023

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +28 more
Nov 18, 2022

MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Hackensack, New Jersey
  • +6 more
Nov 18, 2022

Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +43 more
Nov 17, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Allogeneic Stem Cell Transplantation Trial in United States

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Boston, Massachusetts
  • +5 more
Oct 21, 2022

Acute Myeloid Leukemia Trial in United States (Cytarabine, Daunorubicin, Uproleselan)

Suspended
  • Acute Myeloid Leukemia
  • Little Rock, Arkansas
  • +187 more
Aug 17, 2022

Acute Myeloid Leukemia Trial in Worldwide (SEL24/MEN1703)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Atlanta, Georgia
  • +14 more
Aug 3, 2022

Acute Myeloid Leukemia Trial in Canada, Spain, United States (Decitabine and Cedazuridine (ASTX727), Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +15 more
Jul 29, 2022

Acute Myeloid Leukemia, AML, Adult Trial in United States (evorpacept, venetoclax, azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • AML, Adult
  • Chicago, Illinois
  • +4 more
Jun 7, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

Recruiting
  • Acute Myeloid Leukemia
  • +12 more
  • Los Angeles, California
  • +6 more
Jun 1, 2022

Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Denver, Colorado
  • +8 more
May 19, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • SY-1425 (tamibarotene)
  • +2 more
  • Hartford, Connecticut
  • +25 more
May 4, 2022

Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +13 more
  • Birmingham, Alabama
  • +187 more
Apr 28, 2022

Acute Myeloid Leukemia Trial in Worldwide (Uproleselan, Placebo)

Active, not recruiting
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +69 more
Apr 5, 2022

Acute Myeloid Leukemia Trial in United States (Sapacitabine, Arm A, Sapacitabine, Arm B, Sapacitabine, Arm C)

Completed
  • Acute Myeloid Leukemia
  • Sapacitabine, Arm A
  • +8 more
  • Birmingham, Alabama
  • +14 more
Mar 23, 2022

Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • FT-2102 (olutasidenib)
  • +2 more
  • Los Angeles, California
  • +59 more
Mar 2, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, MDS Trial in United States (CliniMacs TCR alpha-beta-Biotin system)

Enrolling by invitation
  • Acute Lymphoblastic Leukemia
  • +2 more
  • CliniMacs TCR alpha-beta-Biotin system
  • Los Angeles, California
  • +9 more
Feb 10, 2022

Acute Myeloid Leukemia, Myeloid Dysplastic Syndrome Trial in Worldwide (Guadecitabine)

Terminated
  • Acute Myeloid Leukemia
  • Myeloid Dysplastic Syndrome
  • Buffalo, New York
  • +20 more
Jan 21, 2022

Acute Myeloid Leukemia Trial in United States (ASTX660, ASTX727)

Active, not recruiting
  • Acute Myeloid Leukemia
  • San Francisco, California
  • +14 more
Jan 24, 2022

Acute Myeloid Leukemia Trial in United States (SL-401)

Terminated
  • Acute Myeloid Leukemia
  • Tampa, Florida
  • +6 more
Jan 13, 2022